Novel organic compounds (1～8) were designed,synthesized and characterized by IR,1H NMR,H RMS,and single-crystal X-ray crystallography.The anticancer activities of these compounds were investigated against four human lung cancer cells (H20,H2227,H69 and H524) by 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay.Furthermore,by taking compounds 1 and 5 as representatives,molecular docking studies supported the biological assay data,suggesting that compared with 1,compound 5 has stronger interaction with protein.